Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3Withdrawn 1Unknown 1

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Thoracic 2Gynecologic 2Sarcoma 1Head & Neck 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 2Locally Advanced Breast Cancer (LABC) 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × advexin × Breast × Clear all
NCT00044993 2013-05-30

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00004038 2013-02-07

Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled
Breast

Breast Neoplasms

NCT00286247 2008-04-01

Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer

Introgen Therapeutics

Phase 2 Completed
60 enrolled
Breast

Locally Advanced Breast Cancer (LABC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡